OWEGO, NY — CPSI Biotech’s CEO and Lead Scientist gave a podium presentation Monday morning at the 2017 ISBiotech 7th Annual Spring Meeting in Washington, DC (March 6-8). The presentation titled “New Technologies for Improved Handling of Cryopreserved Samples”, given by Dr. John M. Baust, focused on the recent research and development activities relating to CPSI’s SmartThaw™ dry thawing device and RevitalICE cell culture reagent.

As part of the presentation, Dr. Baust focused on educating and reviewing attendees’ current cryopreservation practices and the challenges associated with many of protocols, as well as discussing new technologies and development efforts in the area of modulating the cellular-molecular response to cryopreservation as a path to improve cell recovery and function. Dr. Baust also presented data recently collected by CPSI scientists related to thawing of samples cryopreserved in 5 ml cryovials using SmartThaw™, a next generation device developed by CPSI Biotech for controlled and rapid dry thawing.

SmartThaw is targeted for commercial launch in 2017.

Click Here to read the full Press Release: CPSI Scientists Present at ISBiotech 2017_PR20170308

View other CPSI Biotech news and recent patent announcements